# K061569: Smith & Nephew Competitor Deuce Femoral Components

- Pathway: 510(k) (Special)
- Applicant: Smith & Nephew, Inc.
- Decided: Jul 6, 2006 after 30 days
- Product code: NPJ (Prosthesis, Knee Patellofemorotibial, Partial, Semi-Constrained, Cemented, Polymer/Metal/Polymer)
- Device class: 2
- Regulation: 21 CFR 888.3560
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K962137 (1996). 8 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 10 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K042896: Smith & Nephew Hybrid Knee Femoral, Smith & Nephew, Inc. (2005) Summary page 1.
- K052265: Smith & Nephew Competitor Duo Knee Femoral, Smith & Nephew, Inc. (2005) Summary page 1.

## Most influential descendants
- K113038: Smith & Nephew Inc. Unicompartmental and Biocompartmental Knee System Instruments (2012), 0 descendants of its own

## Indications for use
The Competitor Deuce femoral components are intended to be used for those patients whereby conditions exist that can not be solely addressed by a device that treats a single compartment (i.e. unicondylar or patellofemoral prosthesis) of the knee. Indications include: * Post-traumatic arthritis; * Degenerative arthritis; and * Failed osteotomies, hemiarthroplasties; and unicompartmental replacement These indications will be used for the Competitor Deuce femoral components, whereby the medial condyle and patellofemoral regions have been affected by one or more of these conditions. The Competitor Deuce femoral components are single use only and are intended for implantation only with bone cement.

Source page: https://510kreport.com/device/K061569
Methodology: https://510kreport.com/methodology